Suchergebnisse - "Daratumumab"

PubPharm (866)

1

CD38 and BCL2 expression guides treatment with daratumumab and venetoclax in tagraxofusp-refractory blastic plasmacytoid dendritic cell neoplasm (BPDCN) featuring dynamic loss of CD123

enthalten in: Leukemia research | 2024

von Hu, X. | Ediriwickrema, A. | Saleem, A. | +3

2

Novel monoclonal antibodies : A really specific therapy for light chain amyloidosis

enthalten in: Hematological oncology | 2024

von Del Giudice, M. | Galimberti, S. | Buda, G.

3

Four-Drug Therapy for Multiple Myeloma

enthalten in: The New England journal of medicine | 2024

von Sampath, V.

CommentOn: N Engl J Med. 2024 Jan 25;390(4):301-313. - PMID 38084760

4

Four-Drug Therapy for Multiple Myeloma. Reply

enthalten in: The New England journal of medicine | 2024

von Sonneveld, P.

CommentOn: N Engl J Med. 2024 Jan 25;390(4):301-313. - PMID 38084760

5

Adjusted Indirect Treatment Comparison of Progression-Free Survival with D-Rd and VRd Based on MAIA and SWOG S0777 Individual Patient-Level Data

enthalten in: Advances in therapy | 2024

von Durie, B. | Kumar, S. | Ammann, E. | +5

6

Extramedullary relapse of multiple myeloma presenting as space-occupying lesion in liver treated with daratumumab, pomalidomide, dexamethasone and bendamustine

enthalten in: BMJ case reports | 2024

von Wadhera, S. | Jain, A. | Mitra, S. | +1

7

A validated LC-MS/MS method for the quantitation of daratumumab in rat serum using rapid tryptic digestion without IgG purification and reduction

enthalten in: Journal of pharmaceutical and biomedical analysis | 2024

von Li, W. | Huang, W. | Yu, X. | +6

8

CD56 expression predicts response to Daratumumab-based regimens

enthalten in: Blood cancer journal | 2024

von Robinette, A. | Huric, L. | Dona, K. | +2

9

Donor-specific antibody desensitization with daratumumab prior to haematopoietic cell transplant for sickle cell disease : A case report

enthalten in: British journal of haematology | 2024

von Kunvarjee, B. | Contreras Yametti, G. | Blouin, A. | +13

10

Efficacy and safety of daratumumab, pomalidomide, and dexamethasone versus daratumumab, carfilzomib, and dexamethasone in daratumumab-naïve relapsed multiple myeloma

enthalten in: European journal of haematology | 2024

von Dima, D. | Mansour, R. | Davis, J. | +9

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[87]